Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CNSP
#4005
CNS Pharmaceuticals, Inc. Common Stock
3.1
6
+4.29%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+4.29%
Mudança mensal
-48.11%
Mudança em 6 meses
-49.76%
Mudança anual
+35.62%
Fechamento anterior
3.0
3
Open
3.1
7
Bid
Ask
Low
3.0
9
High
3.1
7
Volume
4
Mercados
Ações
Cuidados de saúde
CNSP
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-6.8 M
-5.47 M
-3.24 M
-5.34 M
-2.17 M
-16.23 M
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
12.28 M
4.96 M
9.83 M
4.43 M
-91.62 K
19.13 M
Free cash flow
-6.8 M
-5.47 M
-3.24 M
-5.34 M
-2.17 M
-16.23 M
Notícias
CNS 파마슈티컬, 경영진에 3명의 임원 새로 임명
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero, DDoS 방어 플랫폼 기능 강화 발표
Corero Network Security reports DDoS protection platform enhancements
CNS Pharmaceuticals, CEO 사임 후 주가 하락
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals, CEO에 라미 레빈 임명
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS Pharmaceuticals, 주주총회서 주식 수 증가 및 이사 선임 승인
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript